Nr566 Week 8 Final Exam Due 1St March
2026 Complete Actual Exam Questions 1- 100
Nr566 Advanced Pharmacology For Care Of
The Family Nr 566 Midterm And Finals
Examplify Online Proctored Exam Actual
Questions And Correct Answers (Verified
Answers)
Original
Core Domains
• Pharmacokinetics and Pharmacodynamics in Family Care
• Pharmacogenomics and Personalized Prescribing
• Pharmacotherapy for Infectious Diseases
• Pharmacotherapy for Cardiovascular Disorders
• Pharmacotherapy for Endocrine Disorders
• Pharmacotherapy for Respiratory Disorders
• Pharmacotherapy for Neurological and Psychiatric Disorders
• Pharmacotherapy for Gastrointestinal and Genitourinary
Disorders
• Pharmacotherapy for Musculoskeletal and Inflammatory
Disorders
, • Pharmacotherapy for Dermatologic and Ophthalmic Disorders
• Health Promotion, Weight Management, and Special Populations
Introduction
This comprehensive examination assesses the family nurse practitioner's
mastery of advanced pharmacology for safe and effective prescribing
across the lifespan. It evaluates knowledge of pharmacokinetic
principles, pharmacodynamic mechanisms, pharmacogenomic
considerations, and evidence-based pharmacotherapy for infectious,
cardiovascular, endocrine, respiratory, neurologic, psychiatric,
gastrointestinal, musculoskeletal, and dermatologic conditions. The
multiple-choice and scenario-based format emphasizes real-world
application, critical thinking, and clinical decision-making. Candidates
are tested on their ability to integrate pharmacotherapeutic knowledge
with patient-specific factors, adverse effect monitoring, and regulatory
compliance to optimize therapeutic outcomes for families.
SECTION ONE: QUESTIONS 1–100
Question 1
A 68-year-old patient with chronic kidney disease (eGFR 28 mL/min)
requires treatment for a urinary tract infection. Which fluoroquinolone
requires dose adjustment in renal impairment?
A. Moxifloxacin
B. Levofloxacin
,C. Ciprofloxacin
D. Both B and C
D. Both B and C
RATIONALE: Levofloxacin and ciprofloxacin are primarily
eliminated by renal excretion and require dose adjustment in patients
with CKD. Moxifloxacin is hepatically metabolized and does not require
renal dose adjustment. The appropriate use of renally cleared antibiotics
in CKD prevents drug accumulation and toxicity.
Question 2
A 72-year-old female with osteoporosis is prescribed alendronate. Which
instruction should the nurse practitioner include in patient education?
A. Take the medication at bedtime with a light snack
B. Take the medication with a full glass of water on an empty stomach
and remain upright for 30 minutes
C. Take the medication with calcium supplements to enhance absorption
D. Crush the tablet if swallowing is difficult
B. Take the medication with a full glass of water on an empty
stomach and remain upright for 30 minutes
RATIONALE: Alendronate must be taken on an empty stomach
with 6–8 ounces of plain water, and the patient must remain upright for
at least 30 minutes to prevent esophageal irritation and ulceration. It
should not be taken with calcium, antacids, or other medications.
Crushing the tablet increases the risk of esophageal irritation.
Question 3
, A 55-year-old male with type 2 diabetes and a history of heart failure
(HFrEF) requires a medication to reduce cardiovascular risk. Which
SGLT2 inhibitor has proven mortality benefit in HFrEF?
A. Canagliflozin
B. Empagliflozin
C. Sitagliptin
D. Glipizide
B. Empagliflozin
RATIONALE: Empagliflozin has demonstrated a significant
reduction in cardiovascular death and heart failure hospitalization in
patients with HFrEF. The EMPEROR-Reduced trial established this
benefit. SGLT2 inhibitors are now a cornerstone of HFrEF management,
regardless of diabetes status. Sitagliptin is a DPP-4 inhibitor, and
glipizide is a sulfonylurea with no cardiovascular mortality benefit.
Question 4
A 62-year-old patient with atrial fibrillation is prescribed apixaban.
Which laboratory parameter should be monitored periodically?
A. INR
B. aPTT
C. Serum creatinine
D. Platelet count only
C. Serum creatinine
RATIONALE: Apixaban is a direct factor Xa inhibitor that does not
require routine INR or aPTT monitoring. However, renal function should
be assessed at least annually and more frequently in patients with renal
2026 Complete Actual Exam Questions 1- 100
Nr566 Advanced Pharmacology For Care Of
The Family Nr 566 Midterm And Finals
Examplify Online Proctored Exam Actual
Questions And Correct Answers (Verified
Answers)
Original
Core Domains
• Pharmacokinetics and Pharmacodynamics in Family Care
• Pharmacogenomics and Personalized Prescribing
• Pharmacotherapy for Infectious Diseases
• Pharmacotherapy for Cardiovascular Disorders
• Pharmacotherapy for Endocrine Disorders
• Pharmacotherapy for Respiratory Disorders
• Pharmacotherapy for Neurological and Psychiatric Disorders
• Pharmacotherapy for Gastrointestinal and Genitourinary
Disorders
• Pharmacotherapy for Musculoskeletal and Inflammatory
Disorders
, • Pharmacotherapy for Dermatologic and Ophthalmic Disorders
• Health Promotion, Weight Management, and Special Populations
Introduction
This comprehensive examination assesses the family nurse practitioner's
mastery of advanced pharmacology for safe and effective prescribing
across the lifespan. It evaluates knowledge of pharmacokinetic
principles, pharmacodynamic mechanisms, pharmacogenomic
considerations, and evidence-based pharmacotherapy for infectious,
cardiovascular, endocrine, respiratory, neurologic, psychiatric,
gastrointestinal, musculoskeletal, and dermatologic conditions. The
multiple-choice and scenario-based format emphasizes real-world
application, critical thinking, and clinical decision-making. Candidates
are tested on their ability to integrate pharmacotherapeutic knowledge
with patient-specific factors, adverse effect monitoring, and regulatory
compliance to optimize therapeutic outcomes for families.
SECTION ONE: QUESTIONS 1–100
Question 1
A 68-year-old patient with chronic kidney disease (eGFR 28 mL/min)
requires treatment for a urinary tract infection. Which fluoroquinolone
requires dose adjustment in renal impairment?
A. Moxifloxacin
B. Levofloxacin
,C. Ciprofloxacin
D. Both B and C
D. Both B and C
RATIONALE: Levofloxacin and ciprofloxacin are primarily
eliminated by renal excretion and require dose adjustment in patients
with CKD. Moxifloxacin is hepatically metabolized and does not require
renal dose adjustment. The appropriate use of renally cleared antibiotics
in CKD prevents drug accumulation and toxicity.
Question 2
A 72-year-old female with osteoporosis is prescribed alendronate. Which
instruction should the nurse practitioner include in patient education?
A. Take the medication at bedtime with a light snack
B. Take the medication with a full glass of water on an empty stomach
and remain upright for 30 minutes
C. Take the medication with calcium supplements to enhance absorption
D. Crush the tablet if swallowing is difficult
B. Take the medication with a full glass of water on an empty
stomach and remain upright for 30 minutes
RATIONALE: Alendronate must be taken on an empty stomach
with 6–8 ounces of plain water, and the patient must remain upright for
at least 30 minutes to prevent esophageal irritation and ulceration. It
should not be taken with calcium, antacids, or other medications.
Crushing the tablet increases the risk of esophageal irritation.
Question 3
, A 55-year-old male with type 2 diabetes and a history of heart failure
(HFrEF) requires a medication to reduce cardiovascular risk. Which
SGLT2 inhibitor has proven mortality benefit in HFrEF?
A. Canagliflozin
B. Empagliflozin
C. Sitagliptin
D. Glipizide
B. Empagliflozin
RATIONALE: Empagliflozin has demonstrated a significant
reduction in cardiovascular death and heart failure hospitalization in
patients with HFrEF. The EMPEROR-Reduced trial established this
benefit. SGLT2 inhibitors are now a cornerstone of HFrEF management,
regardless of diabetes status. Sitagliptin is a DPP-4 inhibitor, and
glipizide is a sulfonylurea with no cardiovascular mortality benefit.
Question 4
A 62-year-old patient with atrial fibrillation is prescribed apixaban.
Which laboratory parameter should be monitored periodically?
A. INR
B. aPTT
C. Serum creatinine
D. Platelet count only
C. Serum creatinine
RATIONALE: Apixaban is a direct factor Xa inhibitor that does not
require routine INR or aPTT monitoring. However, renal function should
be assessed at least annually and more frequently in patients with renal
